home / stock / rxst / rxst quote
Last: | $60.17 |
---|---|
Change Percent: | -1.0% |
Open: | $59.69 |
Close: | $60.17 |
High: | $60.81 |
Low: | $58.6825 |
Volume: | 1,396,531 |
Last Trade Date Time: | 06/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$60.17 | $59.69 | $60.17 | $60.81 | $58.6825 | 1,396,531 | 06-28-2024 |
$59.1 | $57.15 | $59.1 | $59.4 | $56.59 | 459,268 | 06-27-2024 |
$57.13 | $55.76 | $57.13 | $57.19 | $55.35 | 466,828 | 06-26-2024 |
$56.17 | $56.1 | $56.17 | $57.48 | $55.67 | 321,640 | 06-25-2024 |
$55.77 | $56.81 | $55.77 | $57.14 | $55.22 | 517,716 | 06-24-2024 |
$56.74 | $55.92 | $56.74 | $56.79 | $53.72 | 747,909 | 06-21-2024 |
$55.96 | $57.07 | $55.96 | $57.33 | $55.2473 | 252,514 | 06-20-2024 |
$57.07 | $55.76 | $57.07 | $57.64 | $55.11 | 305,638 | 06-19-2024 |
$57.07 | $55.76 | $57.07 | $57.64 | $55.11 | 305,638 | 06-18-2024 |
$56.11 | $57.91 | $56.11 | $58.94 | $55.4201 | 742,964 | 06-17-2024 |
$57.89 | $59.03 | $57.89 | $59.03 | $57.24 | 398,278 | 06-14-2024 |
$59.34 | $58.08 | $59.34 | $59.405 | $57.4 | 340,947 | 06-13-2024 |
$58.08 | $59 | $58.08 | $60.05 | $57.77 | 395,417 | 06-12-2024 |
$57.52 | $58.53 | $57.52 | $58.7734 | $57.13 | 481,074 | 06-11-2024 |
$58.95 | $56.76 | $58.95 | $59.77 | $56.4 | 482,250 | 06-10-2024 |
$57.22 | $57.66 | $57.22 | $58.7865 | $56.98 | 242,097 | 06-07-2024 |
$58.71 | $58.2 | $58.71 | $59.05 | $57.13 | 310,746 | 06-06-2024 |
$58.59 | $57 | $58.59 | $59.47 | $56.42 | 375,266 | 06-05-2024 |
$57.03 | $56.55 | $57.03 | $57.45 | $55.28 | 336,431 | 06-04-2024 |
$56.55 | $58.72 | $56.55 | $59.31 | $56.33 | 502,007 | 06-03-2024 |
News, Short Squeeze, Breakout and More Instantly...
RxSight Inc. Company Name:
RXST Stock Symbol:
NASDAQ Market:
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...
ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it has closed its underwritten public offering of 2,053,571 s...